US Stock MarketDetailed Quotes

BBIO BridgeBio Pharma

Watchlist

25.300
-0.180-0.71%

Trading Nov 4 15:16 ET

4.76BMarket Cap-9583P/E (TTM)

BridgeBio Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

32.11%2.17M

11,461.88%211.12M

-88.02%9.3M

-6.68%1.75M

1,110.36%4.09M

-97.77%1.64M

7.79%1.83M

11.38%77.65M

-85.49%1.87M

-85.58%338K

Operating revenue

32.11%2.17M

11,461.88%211.12M

-88.02%9.3M

-6.68%1.75M

1,110.36%4.09M

-97.77%1.64M

7.79%1.83M

11.38%77.65M

-85.49%1.87M

-85.58%338K

Cost of revenue

-0.17%598K

-8.14%598K

-28.77%2.45M

-7.57%598K

-19.08%598K

-14.43%599K

-51.71%651K

10.28%3.43M

-58.28%647K

-49.17%739K

Gross profit

50.67%1.57M

17,816.77%210.52M

-90.76%6.86M

-6.21%1.15M

971.07%3.49M

-98.57%1.04M

239.60%1.18M

11.43%74.21M

-89.21%1.22M

-145.06%-401K

Operating expense

21.31%174.22M

66.80%206.78M

11.73%606.3M

44.84%177.81M

30.08%160.91M

-0.84%143.61M

-18.10%123.97M

-15.64%542.65M

-30.62%122.76M

-17.75%123.7M

Selling and administrative expenses

64.78%59.52M

111.54%65.81M

5.17%150.59M

49.34%47.58M

14.71%35.78M

-0.83%36.12M

-28.84%31.11M

-25.50%143.19M

-41.80%31.86M

-32.32%31.19M

Research and development costs

6.70%114.7M

51.81%140.97M

14.08%455.71M

43.26%130.23M

35.27%125.14M

-0.84%107.49M

-13.74%92.86M

-11.43%399.46M

-25.61%90.9M

-11.31%92.51M

Operating profit

-21.10%-172.65M

103.05%3.74M

-27.97%-599.44M

-45.35%-176.66M

-26.85%-157.42M

-98.62%-142.57M

18.69%-122.79M

18.76%-468.44M

26.61%-121.54M

16.99%-124.1M

Net non-operating interest income expense

-10.34%-17.74M

-21.47%-19.4M

13.23%-63.25M

7.60%-14.69M

5.14%-16.51M

17.59%-16.08M

20.47%-15.97M

-59.70%-72.9M

-6.33%-15.9M

-60.69%-17.41M

Non-operating interest income

15.09%5.2M

-1.88%4.08M

139.17%18.04M

36.31%5.58M

56.93%3.79M

489.30%4.51M

1,455.43%4.15M

565.67%7.54M

2,148.35%4.09M

932.91%2.42M

Non-operating interest expense

11.38%22.94M

16.65%23.47M

1.06%81.29M

1.39%20.27M

2.43%20.31M

1.55%20.59M

-1.10%20.12M

71.96%80.44M

32.09%19.99M

79.14%19.83M

Other net income (expense)

5,688.61%114.85M

-416.55%-20.51M

-83.34%9.44M

771.48%21.02M

-522.43%-5.56M

-102.32%-2.06M

86.87%-3.97M

58.23%56.68M

-111.07%-3.13M

292.25%1.32M

Gain on sale of security

----

323.17%18.3M

----

113.51%1.4M

----

---8.2M

----

Earnings from equity interest

---7.93M

----

--0

----

Special income (charges)

3,563.69%122.3M

-790.18%-29.99M

81.77%-9.13M

227.08%2.45M

-522.43%-5.56M

57.94%-3.53M

88.86%-3.37M

-239.76%-50.07M

-106.83%-1.93M

292.25%1.32M

-Less：Restructuring and merger&acquisition

-18.13%2.89M

-7.12%3.13M

-74.47%7.93M

-90.20%754K

-94.50%272K

-57.94%3.53M

-66.34%3.37M

--31.05M

--7.69M

--4.95M

-Less:Impairment of capital assets

--0

--271K

--0

--12.72M

--0

--67K

-Less:Other special charges

----

--26.59M

----

-Gain on sale of business

--125.19M

----

---1.2M

----

--0

----

-Gain on sale of property,plant,equipment

----

-183.45%-5.28M

----

-117.59%-6.3M

-79.64%5.76M

1,025.58%6.33M

Other non- operating income (expenses)

515.79%468K

1,677.87%9.48M

-99.77%270K

----

-99.93%76K

---601K

--114.95M

--7M

----

Income before tax

52.99%-75.54M

74.67%-36.16M

-34.79%-653.25M

-21.17%-170.33M

-28.03%-179.49M

-6,179.91%-160.7M

29.11%-142.73M

17.36%-484.65M

7.69%-140.57M

12.93%-140.19M

Income tax

Net income

52.99%-75.54M

74.67%-36.16M

-34.79%-653.25M

-21.17%-170.33M

-28.03%-179.49M

-6,179.91%-160.7M

29.11%-142.73M

17.36%-484.65M

7.69%-140.57M

12.93%-140.19M

Net income continuous Operations

52.99%-75.54M

74.67%-36.16M

-34.79%-653.25M

-21.17%-170.33M

-28.03%-179.49M

-6,179.91%-160.7M

29.11%-142.73M

17.36%-484.65M

7.69%-140.57M

12.93%-140.19M

Minority interest income

25.53%-2.09M

63.35%-944K

-189.68%-10.05M

26.82%-2.18M

12.79%-2.49M

-138.43%-2.8M

47.78%-2.58M

85.49%-3.47M

41.65%-2.98M

43.83%-2.85M

Net income attributable to the parent company

53.48%-73.46M

74.87%-35.22M

-33.67%-643.2M

-22.21%-168.15M

-28.88%-177M

-1,502.06%-157.9M

28.64%-140.16M

14.46%-481.18M

6.51%-137.59M

11.93%-137.34M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

53.48%-73.46M

74.87%-35.22M

-33.67%-643.2M

-22.21%-168.15M

-28.88%-177M

-1,502.06%-157.9M

28.64%-140.16M

14.46%-481.18M

6.51%-137.59M

11.93%-137.34M

Basic earnings per share

60.20%-0.39

78.26%-0.2

-21.17%-3.95

-4.35%-0.96

-16.13%-1.08

-1,300.00%-0.98

31.85%-0.92

16.41%-3.26

8.91%-0.92

12.26%-0.93

Diluted earnings per share

60.20%-0.39

78.26%-0.2

-21.17%-3.95

-4.35%-0.96

-16.13%-1.08

-1,300.00%-0.98

31.85%-0.92

16.41%-3.26

8.91%-0.92

12.26%-0.93

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	32.11%2.17M	11,461.88%211.12M	-88.02%9.3M	-6.68%1.75M	1,110.36%4.09M	-97.77%1.64M	7.79%1.83M	11.38%77.65M	-85.49%1.87M	-85.58%338K
Operating revenue	32.11%2.17M	11,461.88%211.12M	-88.02%9.3M	-6.68%1.75M	1,110.36%4.09M	-97.77%1.64M	7.79%1.83M	11.38%77.65M	-85.49%1.87M	-85.58%338K
Cost of revenue	-0.17%598K	-8.14%598K	-28.77%2.45M	-7.57%598K	-19.08%598K	-14.43%599K	-51.71%651K	10.28%3.43M	-58.28%647K	-49.17%739K
Gross profit	50.67%1.57M	17,816.77%210.52M	-90.76%6.86M	-6.21%1.15M	971.07%3.49M	-98.57%1.04M	239.60%1.18M	11.43%74.21M	-89.21%1.22M	-145.06%-401K
Operating expense	21.31%174.22M	66.80%206.78M	11.73%606.3M	44.84%177.81M	30.08%160.91M	-0.84%143.61M	-18.10%123.97M	-15.64%542.65M	-30.62%122.76M	-17.75%123.7M
Selling and administrative expenses	64.78%59.52M	111.54%65.81M	5.17%150.59M	49.34%47.58M	14.71%35.78M	-0.83%36.12M	-28.84%31.11M	-25.50%143.19M	-41.80%31.86M	-32.32%31.19M
Research and development costs	6.70%114.7M	51.81%140.97M	14.08%455.71M	43.26%130.23M	35.27%125.14M	-0.84%107.49M	-13.74%92.86M	-11.43%399.46M	-25.61%90.9M	-11.31%92.51M
Operating profit	-21.10%-172.65M	103.05%3.74M	-27.97%-599.44M	-45.35%-176.66M	-26.85%-157.42M	-98.62%-142.57M	18.69%-122.79M	18.76%-468.44M	26.61%-121.54M	16.99%-124.1M
Net non-operating interest income expense	-10.34%-17.74M	-21.47%-19.4M	13.23%-63.25M	7.60%-14.69M	5.14%-16.51M	17.59%-16.08M	20.47%-15.97M	-59.70%-72.9M	-6.33%-15.9M	-60.69%-17.41M
Non-operating interest income	15.09%5.2M	-1.88%4.08M	139.17%18.04M	36.31%5.58M	56.93%3.79M	489.30%4.51M	1,455.43%4.15M	565.67%7.54M	2,148.35%4.09M	932.91%2.42M
Non-operating interest expense	11.38%22.94M	16.65%23.47M	1.06%81.29M	1.39%20.27M	2.43%20.31M	1.55%20.59M	-1.10%20.12M	71.96%80.44M	32.09%19.99M	79.14%19.83M
Other net income (expense)	5,688.61%114.85M	-416.55%-20.51M	-83.34%9.44M	771.48%21.02M	-522.43%-5.56M	-102.32%-2.06M	86.87%-3.97M	58.23%56.68M	-111.07%-3.13M	292.25%1.32M
Gain on sale of security	----	----	323.17%18.3M	----	----	113.51%1.4M	----	---8.2M	----	----
Earnings from equity interest	---7.93M	----	----	----	----	--0	----	----	----	----
Special income (charges)	3,563.69%122.3M	-790.18%-29.99M	81.77%-9.13M	227.08%2.45M	-522.43%-5.56M	57.94%-3.53M	88.86%-3.37M	-239.76%-50.07M	-106.83%-1.93M	292.25%1.32M
-Less：Restructuring and merger&acquisition	-18.13%2.89M	-7.12%3.13M	-74.47%7.93M	-90.20%754K	-94.50%272K	-57.94%3.53M	-66.34%3.37M	--31.05M	--7.69M	--4.95M
-Less:Impairment of capital assets	--0	--271K	--0	--0	--0	--0	--0	--12.72M	--0	--67K
-Less:Other special charges	----	--26.59M	----	----	----	----	----	----	----	----
-Gain on sale of business	--125.19M	----	---1.2M	----	----	--0	----	----	----	----
-Gain on sale of property,plant,equipment	----	----	----	----	-183.45%-5.28M	----	----	-117.59%-6.3M	-79.64%5.76M	1,025.58%6.33M
Other non- operating income (expenses)	515.79%468K	1,677.87%9.48M	-99.77%270K	----	----	-99.93%76K	---601K	--114.95M	--7M	----
Income before tax	52.99%-75.54M	74.67%-36.16M	-34.79%-653.25M	-21.17%-170.33M	-28.03%-179.49M	-6,179.91%-160.7M	29.11%-142.73M	17.36%-484.65M	7.69%-140.57M	12.93%-140.19M
Income tax
Net income	52.99%-75.54M	74.67%-36.16M	-34.79%-653.25M	-21.17%-170.33M	-28.03%-179.49M	-6,179.91%-160.7M	29.11%-142.73M	17.36%-484.65M	7.69%-140.57M	12.93%-140.19M
Net income continuous Operations	52.99%-75.54M	74.67%-36.16M	-34.79%-653.25M	-21.17%-170.33M	-28.03%-179.49M	-6,179.91%-160.7M	29.11%-142.73M	17.36%-484.65M	7.69%-140.57M	12.93%-140.19M
Minority interest income	25.53%-2.09M	63.35%-944K	-189.68%-10.05M	26.82%-2.18M	12.79%-2.49M	-138.43%-2.8M	47.78%-2.58M	85.49%-3.47M	41.65%-2.98M	43.83%-2.85M
Net income attributable to the parent company	53.48%-73.46M	74.87%-35.22M	-33.67%-643.2M	-22.21%-168.15M	-28.88%-177M	-1,502.06%-157.9M	28.64%-140.16M	14.46%-481.18M	6.51%-137.59M	11.93%-137.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	53.48%-73.46M	74.87%-35.22M	-33.67%-643.2M	-22.21%-168.15M	-28.88%-177M	-1,502.06%-157.9M	28.64%-140.16M	14.46%-481.18M	6.51%-137.59M	11.93%-137.34M
Basic earnings per share	60.20%-0.39	78.26%-0.2	-21.17%-3.95	-4.35%-0.96	-16.13%-1.08	-1,300.00%-0.98	31.85%-0.92	16.41%-3.26	8.91%-0.92	12.26%-0.93
Diluted earnings per share	60.20%-0.39	78.26%-0.2	-21.17%-3.95	-4.35%-0.96	-16.13%-1.08	-1,300.00%-0.98	31.85%-0.92	16.41%-3.26	8.91%-0.92	12.26%-0.93
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data